AP
U.N.
Pfizer Inc.’s
China National Pharmaceutical Group
Xinhua News Agency
the National Medical Products Administration
Sinovac and Sinopharm
the Communist Party
Sinovac’s
Lancet
COVID-19
CanSino
Longcom Biologic Pharmacy Co.
Sinopharm
Sun Chunlan
Fahrenheit
Olivia Zhang
Chinese
Latin American
Europe
No matching tags
TAIPEI
Taiwan
China
Britain
Russia
Egypt
Mexico
the United States
Japan
Beijing
Sinovac
Jiangsu
Nanjing
Sichuan province
Anhui
Zhejiang province
Shanghai
the United Arab Emirates
Jordan
Peru
Argentina
Brazil
Turkey
Indonesia
Pakistan
No matching tags
Others have been approved for emergency use on people deemed at high risk of infection.“We must be prepared for large-scale production,” said Vice Premier Sun Chunlan, who has overseen much of the country’s response, during a visit Wednesday to developers, according to the official Xinhua News Agency.Sun visited one of Sinopharm’s Beijing subsidiary companies; another producer, Sinovac, and a research lab under the National Medical Products Administration, a regulatory agency that approves medical products for public use.The government has yet to say how many people it plans to vaccinate.
As said here by HUIZHONG WU